Supplementary Materials

Supplementary Material for:

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

Ype P. de Jong,* Marcus Dorner, Michiel C. Mommersteeg, Jing W. Xiao, Alejandro B. Balazs, Justin B. Robbins, Benjamin Y. Winer, Sherif Gerges, Kevin Vega, Rachael N. Labitt, Bridget M. Donovan, Erick Giang, Anuradha Krishnan, Luis Chiriboga, Michael R. Charlton, Dennis R. Burton, David Baltimore, Mansun Law, Charles M. Rice, Alexander Ploss*

*Corresponding author. E-mail: ydj2001{at}med.cornell.edu (Y.P.d.J.); aploss{at}princeton.edu (A.P.)

Published 17 September 2014, Sci. Transl. Med. 6, 254ra129 (2014)
DOI: 10.1126/scitranslmed.3009512

This PDF file includes:

  • Fig. S1. Human hepatocyte engraftment in Fah−/− NOD Rag1−/− IL2Rγcnull mice.
  • Fig. S2. AAV8 vectors affect the liver.
  • Fig. S3. Comparison of synonymous and nonsynonymous mutations in AR- and b6-treated mice.
  • Table S1. Source data.

[Download PDF]